The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
GW693881A ID: ALA1909415
Max Phase: Preclinical
Molecular Formula: C23H17Cl2FN4OS
Molecular Weight: 450.93
Molecule Type: Small molecule
Associated Items:
Representations Synonyms (1): GW693881A Synonyms from Alternative Forms(1):
Canonical SMILES: Cl.Fc1cccc(COc2ccc(Nc3ncnc4cc(-c5ccc[nH]5)sc34)cc2Cl)c1
Standard InChI: InChI=1S/C23H16ClFN4OS.ClH/c24-17-10-16(6-7-20(17)30-12-14-3-1-4-15(25)9-14)29-23-22-19(27-13-28-23)11-21(31-22)18-5-2-8-26-18;/h1-11,13,26H,12H2,(H,27,28,29);1H
Standard InChI Key: PEPUZAMPTKKJFX-UHFFFAOYSA-N
Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Properties Molecular Weight: 450.93Molecular Weight (Monoisotopic): 450.0717AlogP: 6.80#Rotatable Bonds: 6Polar Surface Area: 62.83Molecular Species: NEUTRALHBA: 5HBD: 2#RO5 Violations: 1HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski): 1CX Acidic pKa: CX Basic pKa: 2.91CX LogP: 6.30CX LogD: 6.30Aromatic Rings: 5Heavy Atoms: 31QED Weighted: 0.30Np Likeness Score: -1.75
References 1. Compounds: GSK PKIS; Assays: Nanosyn kinase panel, [10.6019/CHEMBL1961873 ] 2. Compounds: GSK PKIS; Assays: UNC Frye lab, [10.6019/CHEMBL2007661 ] 3. Data associated with the publication PLoS ONE, 8(3), e57888, (2013) PMID: 23505445. Compounds: GSK PKIS; Assays: NIH NCATS,